scispace - formally typeset
V

Veereshwar Bhatnagar

Researcher at All India Institute of Medical Sciences

Publications -  191
Citations -  1958

Veereshwar Bhatnagar is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Biliary atresia & Bladder exstrophy. The author has an hindex of 21, co-authored 184 publications receiving 1737 citations.

Papers
More filters
Journal ArticleDOI

Complications of cerebrospinal fluid shunts

TL;DR: Overall results of the Upadhyayay shunt valve compare favourably with other reported series.
Journal ArticleDOI

Long term outcome of management of antenatally diagnosed pelvi-ureteric junction obstruction.

TL;DR: The conservative management of PUJO, in renal unit with good function, does not lead to any significant deterioration in the function even when delayed pyeloplasty is performed, when indicated.
Journal ArticleDOI

Semen analysis in post-pubertal patients with posterior urethral valves: a pilot study.

TL;DR: Semen abnormalities in the form of increased liquefaction time, abnormal sperm agglutination, and a high percentage of immotile sperm were seen in the present study, and the bearing of these findings on subsequent sexual function and fertility remains a matter of speculation.
Journal ArticleDOI

A survey of musculoskeletal and aesthetic abnormalities after thoracotomy in pediatric patients

TL;DR: The incidences of musculoskeletal and aesthetic abnormalities after posterolateral thoracotomies in children were low and longer follow up of patients after thoracotomy is needed to pick up these abnormalities as the children grow.
Journal ArticleDOI

Primary definitive procedure versus conventional three-staged procedure for the management of low-type anorectal malformation in females: A randomized controlled trial

TL;DR: Females with VF or PF undergoing primary definitive procedure have a significantly higher incidence of wound dehiscence, immediate and early postoperative complications, according to a randomized controlled trial for girls <14 years.